Julian Panés Selected Research

Antibodies

12/2021

Integrin Inhibitors in Inflammatory Bowel Disease: From Therapeutic Antibodies to Small-Molecule Drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julian Panés Research Topics

Disease

21	Ulcerative Colitis 10/2022 - 07/2014
20	Crohn Disease (Crohn's Disease) 11/2022 - 09/2008
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 01/2015
3	Herpes Zoster 10/2022 - 01/2017
3	Infections 10/2022 - 01/2017
3	Skin Neoplasms (Skin Cancer) 01/2022 - 01/2017
3	Inflammation (Inflammations) 03/2021 - 01/2016
2	Fistula 11/2022 - 01/2022
2	Abdominal Pain (Pain, Abdominal) 10/2022 - 01/2022
2	Hemorrhage 01/2022 - 01/2021
2	Necrosis 01/2022 - 03/2021
2	Pathologic Constriction (Stenosis) 01/2018 - 11/2013
2	Disease Progression 12/2013 - 11/2013
1	Choristoma (Ectopic Tissue) 11/2022
1	Acne Vulgaris 01/2022
1	Nasopharyngitis 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Psoriatic Arthritis 01/2021
1	COVID-19 01/2021
1	Ulcer 09/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2019
1	Venous Thromboembolism 11/2019
1	Pulmonary Embolism 11/2019
1	Mucositis 01/2016

Drug/Important Bio-Agent (IBA)

15	tofacitinibIBA 06/2022 - 01/2016
11	Janus Kinase InhibitorsIBA 06/2022 - 11/2016
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 07/2010
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022 - 07/2014
3	upadacitinibIBA 10/2022 - 11/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 11/2020
2	Pharmaceutical PreparationsIBA 10/2022 - 10/2017
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022 - 01/2022
2	Tumor Necrosis Factor InhibitorsIBA 06/2022 - 01/2017
2	Janus Kinase 1IBA 01/2022 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2014
2	Adalimumab (Humira)FDA Link 01/2022 - 12/2013
2	IntegrinsIBA 12/2021 - 10/2017
2	Janus KinasesIBA 11/2021 - 01/2018
2	Biological ProductsIBA 01/2021 - 09/2020
2	Infliximab (Remicade)FDA Link 01/2015 - 07/2010
2	Azathioprine (Imuran)FDA LinkGeneric 11/2013 - 09/2008
1	C-Reactive ProteinIBA 10/2022
1	Contrast MediaIBA 05/2022
1	risankizumabIBA 01/2022
1	etrolizumabIBA 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	Saline SolutionIBA 01/2022
1	InterleukinsIBA 01/2022
1	AntibodiesIBA 12/2021
1	InterferonsIBA 11/2021
1	vedolizumabIBA 03/2021
1	GadoliniumIBA 09/2020
1	Phenobarbital (Luminal)FDA Link 09/2020
1	Capsules (Microcapsules)IBA 01/2018
1	LipidsIBA 01/2017
1	CytokinesIBA 01/2016
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Biosimilar PharmaceuticalsIBA 01/2015
1	Immunologic Factors (Immunomodulators)IBA 11/2013
1	Methotrexate (Mexate)FDA LinkGeneric 11/2013
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 11/2013
1	Certolizumab Pegol FDA Link 07/2010
1	SteroidsIBA 09/2008
1	Everolimus FDA Link 09/2008

Therapy/Procedure

12	Therapeutics 10/2022 - 02/2012
3	Remission Induction 11/2022 - 01/2022
3	Aftercare (After-Treatment) 11/2022 - 11/2021
3	Stem Cell Transplantation 10/2017 - 01/2016
2	Biological Therapy 05/2022 - 01/2022
1	Curettage 01/2022
1	Drug Tapering 07/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 09/2016